Recognized standard
C63.18-2014
FDA recognition 19-17 · IEEE · General II (ES/EMC)
Key facts
| Recognition number | 19-17 |
|---|---|
| Designation | C63.18-2014 |
| Title | American National Standard Recommended Practice for an On-Site, Ad Hoc Test Method for Estimating Electromagnetic Immunity of Medical Devices to Radiated Radio-Frequency (RF) Emissions from RF Transmitters |
| Standards developer | Institute of Electrical and Electronic Engineers |
| Specialty area | General II (ES/EMC) |
| Date of entry | Apr 4, 2016 |
| Scope (excerpt) | This recommended practice is a guide to evaluating the electromagnetic immunity of medical devices to radiated radio-frequency (RF) emissions from common RF transmitters (e.g., two-way radios; walkietalkies; mobile phones; wireless-enabled tablets, e-readers, laptop computers, and similar devices… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: